A new study performed on women with polycystic ovary syndrome (PCOS) and fertility problems has been published in Gynecological Endocrinology. Results of this comparative study showed a striking increase in the pregnancy rate of 65.5% after treatment with 1,100 mg MI+300 mg DCI in contrast to 25.9% in women receiving 40:1 ratio. Based on these results, Biosearch Life has launched a new product with a combination of MI and DCI (Caronositol®) at the 3.6:1 ratio. The objective of this new product is to improve the success of fertility treatments in women affected by PCOS.
